Natasha Foundation clinical trials: Exclusive podcast
“We’re going to have a completely positive outcome for around 80% of the people that will go through the trial and demonstrate that food all along has been the medicine that has been overlooked and it’s not necessary to use expensive drugs that limit the amount of people that can be treated,” said Laperouse.
He also remarked on the practical benefits a positive outcome for the trial would have for the wider food and drink industry.
Industry benefits
“It’s really good news for the food industry on two counts. If the public are desensitised in such a big scale through the NHS, it means things like ‘may contain’ labels will no longer be the big issue they are today,” Laperouse continued.
“Also, cross contamination of food will no longer be a problem, because people who have been desensitised will be able to eat considerable amounts of that food without any problem at all.”
When asked how others in the food and drink industry could do to help combat the threat of allergens and allergic reactions, Laperouse urged business to take the first steps and simply get in touch.
Making a choice
“Just talk with us. I think that's the main thing," he concluded. "Nobody’s holding a gun to anyone’s head here – what we’ve been doing all along is simply explaining the situation of food allergy to the top management and thereafter it’s entirely up to them what they want to do.
“But, if you want to follow in the footsteps of the great and the good of the food industry, get in contact with the foundation and we’d be happy to talk to you and explain some of the big scale national projects we’re working on that will ultimately make food allergy history, once and for all.”
